Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reprometabolic Syndrome Mediates Subfertility in Obesity

NCT02653092 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT02653092
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02653092 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reprometabolic Syndrome Mediates Subfertility in Obesity
Lead sponsor
University of Colorado, Denver
Phase
Not applicable
Overall status
Active, not recruiting
Start date
June 30, 2016
Completion date
December 11, 2026
Enrollment
84 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperinsulinemia, hypogonadotropic hypogonadotropism, infertility, obesity